(Transient ischemic attack)
32,739 results
  • Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study. [Journal Article]
    J Am Heart Assoc. 2026 Aug 20; :e049649. [Online ahead of print]Huang TC, Yap LH, … Li YHJA
  • CONCLUSIONS: Among patients with newly diagnosed AF, baseline SGLT2 inhibitor use was not significantly associated with lower risks of cerebrovascular events or major adverse cardiovascular events. The lower mortality observed in the time-dependent analysis should be interpreted cautiously because of potential residual confounding. SGLT2 inhibitors should not be considered an alternative to guideline-directed oral anticoagulation, which remains the cornerstone of stroke prevention in eligible patients with AF.
  • [Neuroimaging features of white matter lesions related to patent foramen ovale]. [Journal Article]
    Zhonghua Yi Xue Za Zhi. 2026 Aug 25; 106(31):3285-3290.Yi J, Ma YJ, … Li SJZY
  • A retrospective analysis was conducted on the neuroimaging features of white matter lesions related to patent foramen ovale and clinical characteristics (age, sex, history of hypertension and diabetes, etc.) of patients who underwent patent foramen ovale closure surgery at Fuwai Hospital, Chinese Academy of Medical Sciences, from February 2021 to June 2025. All patients were confirmed to have rig…
  • Rare Complications Of A Popular Procedure: A Multi-institutional Case Series of Superior Laryngeal Nerve Block (SLN) Complications. [Journal Article]
    J Voice. 2026 Aug 15. [Online ahead of print]Miller SM, Alanazi AM, … Bensoussan YJV
  • CONCLUSIONS: SLN block is typically a well-tolerated procedure with minimal risks. In this case series, the most frequently reported events were caused by medication interactions with nearby nerves, including the marginal mandibular nerve producing a self-resolving palsy, and the sympathetic chain causing transient Horner's syndrome. As this injection is increasingly performed, we anticipate more reports of these or other uncommon complications in the future, which should be discussed during the consent process.
  • Clinical analysis of 48 patients with carotid web diagnosed by digital subtraction angiography. [Journal Article]
    Front Neurol. 2026; 17:1862595.Huang J, Ding Z, … Zhang YSFN
  • CONCLUSIONS: In this retrospective, non-randomized cohort, the observed rate of recurrent ipsilateral ischemic events was numerically lower among patients who received active endovascular treatment (0/6) than among those who received medical therapy alone (1/34). However, given the very small number of patients who received active intervention, the short follow-up (3-12 months), and the non-randomized, indication-based treatment allocation, no causal inference can be drawn from these data regarding the efficacy of endovascular treatment in preventing stroke recurrence. The observed difference should be interpreted as hypothesis-generating only and requires confirmation in adequately powered prospective randomized controlled trials. Carotid web is an important risk factor for cryptogenic stroke across all age groups. DSA remains the diagnostic gold standard. For patients who have already experienced ischemic events or who have subweb thrombus, active endovascular treatment represents a potentially useful therapeutic option that warrants further evaluation.
  • Postpartum thromboembolism risk by CHA2DS2-VASc score in patients with atrial fibrillation or flutter during pregnancy. [Journal Article]
    Pregnancy (Hoboken). 2025 Sep; 1(5):e70082.Watkins VY, Snow SC, … Federspiel JJP
  • CONCLUSIONS: Pregnant patients with a history of AF/AFL and a CHA2DS2-VASc score ≥ 2 are significantly more likely to experience an acute thromboembolic event following delivery than those with a CHA2DS2-VASc of 1. Additionally, baseline rates of TIA/CVA for pregnant individuals with AF/AFL but no additional risk factors beyond sex were 1.4% during the 6-week postpartum period, suggesting that pregnancy and postpartum states have increased risk not accounted for by the CHA2DS2-VASc score. Prospective studies are needed to better understand risk for pregnant and postpartum patients with AF/AFL and to determine optimal management strategies.